Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
LuAG-06474 by H. Lundbeck for Pain: Likelihood of Approval
LuAG-06474 is under clinical development by H. Lundbeck and currently in Phase I for Pain. According to GlobalData, Phase I...
LuAG-06474 by H. Lundbeck for Unspecified Neurologic Disorders: Likelihood of Approval
LuAG-06474 is under clinical development by H. Lundbeck and currently in Phase I for Unspecified Neurologic Disorders. According to GlobalData,...
Amlenetug by H. Lundbeck for Parkinson's Disease: Likelihood of Approval
Amlenetug is under clinical development by H. Lundbeck and currently in Phase I for Parkinson's Disease. According to GlobalData, Phase...
Vortioxetine hydrobromide by H. Lundbeck for Bipolar Disorder (Manic Depression): Likelihood of Approval
Vortioxetine hydrobromide is under clinical development by H. Lundbeck and currently in Phase II for Bipolar Disorder (Manic Depression). According...
LuAF-82422 by H. Lundbeck for Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration): Likelihood of Approval
LuAF-82422 is under clinical development by H. Lundbeck and currently in Phase II for Multiple System Atrophy (MSA or Shy-Drager...
LuAF-28996 by H. Lundbeck for Parkinson's Disease: Likelihood of Approval
LuAF-28996 is under clinical development by H. Lundbeck and currently in Phase I for Parkinson's Disease. According to GlobalData, Phase...